Metropolis Capital Ltd Grows Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Metropolis Capital Ltd increased its stake in HCA Healthcare by 76.6% during Q2, owning 603,029 shares, which is approximately 7.3% of its investment portfolio.
• HCA Healthcare reported earnings of $6.84 per share for the recent quarter, surpassing analysts' expectations of $6.20, with year-over-year revenue growth of 6.4%.
• The company announced a quarterly dividend of $0.72 per share, resulting in a 0.7% dividend yield and a payout ratio of 12.11%.

Metropolis Capital Ltd grew its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 76.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 603,029 shares of the company's stock after purchasing an additional 261,592 shares during the period. HCA Healthcare comprises approximately 7.3% of Metropolis Capital Ltd's investment portfolio, making the stock its 6th largest position. Metropolis Capital Ltd owned 0.25% of HCA Healthcare worth $231,020,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nuveen LLC acquired a new stake in shares of HCA Healthcare during the first quarter valued at about $569,217,000. Pacer Advisors Inc. boosted its position in HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after buying an additional 1,329,618 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after purchasing an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. increased its holdings in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after purchasing an additional 587,036 shares during the period. Finally, Abdiel Capital Advisors LP bought a new stake in shares of HCA Healthcare in the 1st quarter valued at about $164,835,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Down 0.1%

Shares of HCA opened at $425.85 on Thursday. The stock has a market cap of $99.64 billion, a P/E ratio of 17.90, a P/E/G ratio of 1.34 and a beta of 1.40. The business's fifty day moving average is $393.90 and its 200 day moving average is $371.02. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $429.43.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 12.11%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of recent analyst reports. Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research report on Monday, July 28th. Morgan Stanley dropped their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Cantor Fitzgerald reissued an "overweight" rating and issued a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday, August 26th. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Finally, Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and an average target price of $407.75.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.